linagliptin and semaglutide Type 2 Diabetes Update: as Basal Insulin Alternatives Incretin-based therapies and altered myocardial

How long does EMA approval usually take

Some studies suggest that tirzepatide may lead to greater average weight loss than semaglutide, though long-term outcomes are still being studied

If you are struggling with diabetes or obesity, consider exploring Tirzepatide treatment as part of your journey to better health.

Additionally, the incidence of side effects also depends on individuals tolerance

It helps the body manage glucose and satiety through multiple pathways: Stimulating insulin release Suppressing glucagon (which raises blood sugar) Delaying gastric emptying Acting on the hypothalamus to reduce hunger Semaglutide mimics this activity with greater stability, lasting up to seven days per dose , allowing for once-weekly administration